PLAAT4

phospholipase A and acyltransferase 4, the group of Phospholipase A and acyltransferase family

Basic information

Region (hg38): 11:63536808-63548808

Previous symbols: [ "RARRES3" ]

Links

ENSG00000133321NCBI:5920OMIM:605092HGNC:9869Uniprot:Q9UL19AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PLAAT4 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLAAT4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
18
clinvar
2
clinvar
20
nonsense
0
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 18 3 0

Variants in PLAAT4

This is a list of pathogenic ClinVar variants found in the PLAAT4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-63539559-G-A not specified Uncertain significance (Feb 28, 2023)2456906
11-63539561-C-G not specified Uncertain significance (Feb 07, 2025)3889842
11-63539586-A-T not specified Uncertain significance (Oct 12, 2024)3419819
11-63544632-G-A not specified Uncertain significance (Oct 30, 2023)3214256
11-63544665-A-G not specified Likely benign (Oct 04, 2024)3419821
11-63544692-C-T not specified Uncertain significance (Feb 15, 2023)2460740
11-63544693-G-A not specified Uncertain significance (Jun 06, 2023)2555091
11-63544726-G-A not specified Uncertain significance (Jan 19, 2025)3214257
11-63544726-G-C not specified Uncertain significance (Jul 12, 2022)3214258
11-63544755-CA-C Likely benign (Dec 31, 2019)798040
11-63544761-C-T not specified Uncertain significance (Jun 29, 2022)3214259
11-63544767-G-A not specified Uncertain significance (Aug 28, 2024)3419822
11-63544767-G-C not specified Uncertain significance (Aug 15, 2023)2593221
11-63544799-G-T not specified Uncertain significance (Nov 06, 2023)3214260
11-63544875-T-G not specified Uncertain significance (Aug 30, 2021)3214261
11-63544879-G-A not specified Likely benign (Apr 25, 2022)3214262
11-63546176-G-T not specified Uncertain significance (Jul 17, 2024)3214263
11-63546186-C-T not specified Uncertain significance (Oct 03, 2024)3419820
11-63546212-T-A not specified Uncertain significance (Nov 30, 2022)3214264
11-63546212-T-G not specified Uncertain significance (Feb 22, 2023)2468480
11-63546216-C-G not specified Uncertain significance (Nov 25, 2024)3419823
11-63546220-T-G not specified Uncertain significance (Aug 15, 2023)2619106
11-63546252-C-T not specified Uncertain significance (Mar 06, 2025)3889843

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PLAAT4protein_codingprotein_codingENST00000255688 49654
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.22e-70.05941255930201256130.0000796
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.3628898.10.8970.000006141062
Missense in Polyphen1927.8880.6813328
Synonymous-0.1493937.81.030.00000231321
Loss of Function-1.0396.231.452.64e-779

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001560.000154
Ashkenazi Jewish0.000.00
East Asian0.00005560.0000544
Finnish0.0001850.000185
European (Non-Finnish)0.00009720.0000967
Middle Eastern0.00005560.0000544
South Asian0.000.00
Other0.0001640.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Exhibits PLA1/2 activity, catalyzing the calcium- independent hydrolysis of acyl groups in various phosphatidylcholines (PC) and phosphatidylethanolamine (PE). For most substrates, PLA1 activity is much higher than PLA2 activity. N- and O-acylation activity is hardly detectable. {ECO:0000269|PubMed:19615464}.;
Pathway
Metabolism of lipids;Metabolism;Glycerophospholipid biosynthesis;Phospholipid metabolism;Acyl chain remodelling of PE (Consensus)

Intolerance Scores

loftool
0.723
rvis_EVS
-0.41
rvis_percentile_EVS
26.23

Haploinsufficiency Scores

pHI
0.00106
hipred
Y
hipred_score
0.554
ghis
0.448

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.559

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Gene ontology

Biological process
phospholipid metabolic process;negative regulation of cell population proliferation;lipid catabolic process;phosphatidylethanolamine acyl-chain remodeling
Cellular component
cytosol;integral component of membrane
Molecular function
phospholipase A2 activity;protein binding;transferase activity, transferring acyl groups